In paired specimens derived from individuals with SCLC-A subtype tumours before and after the progression of chemotherapy-refractory disease, we showed that tumour-associated endothelial cells express D2R before exposure to chemotherapy. This evidence concerns the gene DRD2 and neoplasm.